Introduction to Infectious Diseases
In A-Level Biology, infectious diseases, also commonly referred to as communicable diseases, are defined as illnesses caused by pathogenic organisms that can be transmitted from an infected organism to an uninfected organism. This transmission can occur between humans, from animals to humans (zoonotic), or from the environment. These diseases result when a pathogen successfully enters the host, overcomes its immune defences, and begins to replicate, causing damage to cells and tissues, which manifests as signs and symptoms. It is vital to distinguish these from non-infectious diseases, such as cancer or diabetes, which are not caused by a transmissible pathogen but are instead linked to genetics, lifestyle factors, or environmental causes.
The infectious agent responsible for causing the disease is called a pathogen. These organisms possess specific pathogenic factors that contribute to their virulence, which is the degree of damage or disease-causing ability. Understanding the nature of the pathogen and its specific life cycle and mode of transmission is paramount to developing effective strategies for prevention and control, which constitutes a core part of the study of infectious disease in biological sciences.
The Four Major Classes of Pathogens
Pathogens are broadly classified into four major groups, each with unique biological structures and mechanisms of causing disease. These differences dictate the treatment and prevention strategies employed.
The first group is **Bacteria**. These are prokaryotic, single-celled microorganisms. Examples of bacterial diseases include Tuberculosis (TB), caused by *Mycobacterium tuberculosis*, and Cholera, caused by *Vibrio cholerae*. Bacteria can cause disease by directly destroying tissue or by secreting toxins.
The second group is **Viruses**. Viruses are acellular and are obligate intracellular parasites, meaning they are only a genetic material (DNA or RNA) enclosed within a protein coat (capsid) and must hijack the host cell’s machinery to replicate. They cannot be killed by antibiotics. Key examples are the Human Immunodeficiency Virus (HIV), which causes AIDS, and the Influenza virus.
The third group is **Protoctists** (Protozoa). These are eukaryotic, single-celled organisms that are often parasitic. The most significant example is *Plasmodium*, a genus with four species (*P. falciparum, P. vivax, P. malariae, P. ovale*) that cause the disease Malaria.
The final group is **Fungi**. These are eukaryotic organisms that can be single-celled (yeast) or multicellular (moulds). They often cause superficial infections like Athlete’s foot (*Trichophyton*), but can also cause severe systemic diseases, especially in immunocompromised individuals.
Transmission of Disease: Direct and Indirect Routes
The spread of infectious diseases is classified into two primary categories: direct and indirect transmission. Direct transmission involves the immediate transfer of the pathogen from one host to another. This includes direct physical contact, such as sexual intercourse (e.g., Syphilis, HIV), or contact with open lesions. It also encompasses vertical transmission, where a pathogen passes from a mother to her foetus across the placenta.
Indirect transmission involves an intermediary source before the pathogen reaches the final host. This is further subdivided into several modes. **Droplet Spread** (or airborne transmission) occurs when an infected person coughs, sneezes, or talks, releasing droplets containing the pathogen, which are then inhaled by an uninfected person (e.g., TB, Influenza). **Contaminated Food and Water** transmission, often via the faecal-oral route, happens when poor sanitation allows faeces containing pathogens to contaminate the water or food supply (e.g., Cholera). Lastly, **Vectors** are living organisms that transmit the disease from one host to another without themselves getting sick (e.g., the female *Anopheles* mosquito transmits the *Plasmodium* protoctist that causes Malaria.
Case Study: Tuberculosis (TB)
Tuberculosis is a chronic bacterial infection primarily affecting the lungs, though it can spread to other parts of the body like the brain and kidneys. It is caused by the bacterium *Mycobacterium tuberculosis*. The disease is mainly spread through airborne droplet transmission, making it highly contagious in crowded or poorly ventilated spaces.
Upon inhalation, the bacteria are engulfed by phagocytes (a type of white blood cell) in the lungs. Unlike most bacteria, *M. tuberculosis* is able to survive and multiply within the phagocytes. In a person with a healthy immune system, the body seals off these infected phagocytes inside structures called tubercles, causing the disease to become dormant (latent TB). The person shows no symptoms and is not infectious. However, if the immune system is weakened (e.g., due to old age, malnutrition, or HIV/AIDS), the bacteria can become reactivated, leading to active TB. Active disease progressively damages the lung tissue, resulting in characteristic symptoms like a persistent cough, coughing up blood and mucus, night sweats, and severe weight loss, leading to respiratory failure and potentially death.
Case Study: HIV and AIDS
The Human Immunodeficiency Virus (HIV) is a deadly viral pathogen that specifically targets and destroys T helper cells, which are crucial components of the body’s adaptive immune system. HIV is transmitted through the exchange of infected bodily fluids, most commonly via unprotected sexual intercourse, sharing of contaminated needles among drug users, and from mother to child during childbirth or breastfeeding. The virus uses its attachment proteins to bind to receptors on the T helper cells, enter the cell, and integrate its genetic material (RNA) into the host cell’s DNA using the enzyme reverse transcriptase.
Over time, the destruction of T helper cells progressively weakens the immune system. When the T helper cell count drops below a critical threshold, the patient is diagnosed with Acquired Immunodeficiency Syndrome (AIDS). At this stage, the immune system is severely compromised, leaving the individual vulnerable to opportunistic infections and cancers that a healthy immune system would normally fend off. While antiretroviral therapy (ART) can suppress the viral load and significantly prolong the patient’s life, there is currently no cure, highlighting the complexity and evolutionary challenges of viral diseases.
Prevention and Control of Infectious Diseases
The management of infectious diseases relies on a multifaceted approach that considers social, economic, and biological factors. Prevention focuses on breaking the transmission cycle. Simple measures like improving sanitation and hygiene, such as providing clean drinking water and effective sewage systems, are highly effective against faecal-oral diseases like Cholera. Public health education, including promoting safe sexual practices and discouraging needle sharing, is key to preventing the spread of blood-borne viruses like HIV and Hepatitis B/C.
Immunization through **Vaccination** is one of the most effective biological methods. Vaccines expose the body to a harmless form of the pathogen’s antigen, stimulating a primary immune response and the production of memory cells. This confers future immunity, preventing the disease and contributing to ‘herd immunity’ within the population. Furthermore, **Antibiotics** are crucial for treating bacterial infections by selectively killing bacteria or inhibiting their growth. They target specific structures found in bacteria but not in human cells, such as the cell wall, or inhibit key bacterial processes like protein or nucleic acid synthesis.
The Challenge of Antibiotic Resistance
A significant modern challenge in disease control is the escalating issue of antibiotic resistance. This is an evolutionary process where bacteria develop adaptations that allow them to survive exposure to antibiotics. This process is accelerated by the overuse and incorrect use of antibiotics, such as prescribing them for viral infections or patients failing to complete the full course of treatment, leaving resistant bacteria behind to multiply. Examples include Methicillin-resistant *Staphylococcus aureus* (MRSA).
To combat this, strategies include stricter antibiotic prescribing policies, reducing the use of routine antibiotics in agriculture, and promoting better personal hygiene and sanitation to prevent infections in the first place, thus reducing the overall need for antibiotic use. Research and development of new drugs and alternative therapies are also vital to maintain a sustainable medical defence against evolving bacterial pathogens, ensuring that we can continue to effectively treat common bacterial diseases for future generations.